inspire neurocare limited
inspire neurocare limited Company Information
Company Number
11926195
Next Accounts
Sep 2025
Shareholders
hamberley specialist properties (worcester) limited
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
10 lower thames street, london, EC3R 6AF
Website
inspireneurocare.co.ukinspire neurocare limited Estimated Valuation
Pomanda estimates the enterprise value of INSPIRE NEUROCARE LIMITED at £4.8m based on a Turnover of £7.5m and 0.64x industry multiple (adjusted for size and gross margin).
inspire neurocare limited Estimated Valuation
Pomanda estimates the enterprise value of INSPIRE NEUROCARE LIMITED at £0 based on an EBITDA of £-537.5k and a 4.71x industry multiple (adjusted for size and gross margin).
inspire neurocare limited Estimated Valuation
Pomanda estimates the enterprise value of INSPIRE NEUROCARE LIMITED at £0 based on Net Assets of £-192.6k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Inspire Neurocare Limited Overview
Inspire Neurocare Limited is a live company located in london, EC3R 6AF with a Companies House number of 11926195. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 2019, it's largest shareholder is hamberley specialist properties (worcester) limited with a 100% stake. Inspire Neurocare Limited is a young, mid sized company, Pomanda has estimated its turnover at £7.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Inspire Neurocare Limited Health Check
Pomanda's financial health check has awarded Inspire Neurocare Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £7.5m, make it larger than the average company (£4.8m)
- Inspire Neurocare Limited
£4.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 52%, show it is growing at a faster rate (6.7%)
- Inspire Neurocare Limited
6.7% - Industry AVG
Production
with a gross margin of 38.2%, this company has a comparable cost of product (38.2%)
- Inspire Neurocare Limited
38.2% - Industry AVG
Profitability
an operating margin of -8.5% make it less profitable than the average company (5.7%)
- Inspire Neurocare Limited
5.7% - Industry AVG
Employees
with 99 employees, this is above the industry average (27)
99 - Inspire Neurocare Limited
27 - Industry AVG
Pay Structure
on an average salary of £53.9k, the company has an equivalent pay structure (£53.9k)
- Inspire Neurocare Limited
£53.9k - Industry AVG
Efficiency
resulting in sales per employee of £75.7k, this is less efficient (£171.3k)
- Inspire Neurocare Limited
£171.3k - Industry AVG
Debtor Days
it gets paid by customers after 30 days, this is earlier than average (42 days)
- Inspire Neurocare Limited
42 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (32 days)
- Inspire Neurocare Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Inspire Neurocare Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (22 weeks)
3 weeks - Inspire Neurocare Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 109.2%, this is a higher level of debt than the average (62.6%)
109.2% - Inspire Neurocare Limited
62.6% - Industry AVG
INSPIRE NEUROCARE LIMITED financials
Inspire Neurocare Limited's latest turnover from December 2023 is estimated at £7.5 million and the company has net assets of -£192.6 thousand. According to their latest financial statements, Inspire Neurocare Limited has 99 employees and maintains cash reserves of £137.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|
| Turnover | 3,449,726 | 2,415,366 | |||
| Other Income Or Grants | 40,721 | 69,335 | |||
| Cost Of Sales | 2,423,515 | 1,775,011 | |||
| Gross Profit | 1,066,932 | 709,690 | |||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | 1,571,025 | -784,954 | |||
| Tax | 202,366 | 255,748 | |||
| Profit After Tax | 1,773,391 | -529,206 | |||
| Dividends Paid | |||||
| Retained Profit | 1,773,391 | -529,206 | |||
| Employee Costs | |||||
| Number Of Employees | 99 | 82 | 63 | 34 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 164,714 | 193,994 | 328,469 | 426,299 | 12,255 |
| Intangible Assets | |||||
| Investments & Other | |||||
| Debtors (Due After 1 year) | |||||
| Total Fixed Assets | 164,714 | 193,994 | 328,469 | 426,299 | 12,255 |
| Stock & work in progress | |||||
| Trade Debtors | 635,880 | 605,539 | 306,020 | 141,634 | |
| Group Debtors | 1,985 | ||||
| Misc Debtors | 1,160,647 | 909,654 | 528,469 | 226,197 | 307,128 |
| Cash | 137,727 | 136,549 | 136,995 | 190,473 | 5,634 |
| misc current assets | |||||
| total current assets | 1,934,254 | 1,651,742 | 971,484 | 560,289 | 312,762 |
| total assets | 2,098,968 | 1,845,736 | 1,299,953 | 986,588 | 325,017 |
| Bank overdraft | |||||
| Bank loan | |||||
| Trade Creditors | 4,784 | 60,479 | 73,631 | 58,779 | 23,440 |
| Group/Directors Accounts | 1,999,482 | 1,149,150 | 2,374,731 | 1,660,149 | 324,155 |
| other short term finances | |||||
| hp & lease commitments | |||||
| other current liabilities | 287,304 | 194,996 | 183,871 | 70,734 | 16,592 |
| total current liabilities | 2,291,570 | 1,404,625 | 2,632,233 | 1,789,662 | 364,187 |
| loans | |||||
| hp & lease commitments | |||||
| Accruals and Deferred Income | |||||
| other liabilities | |||||
| provisions | |||||
| total long term liabilities | |||||
| total liabilities | 2,291,570 | 1,404,625 | 2,632,233 | 1,789,662 | 364,187 |
| net assets | -192,602 | 441,111 | -1,332,280 | -803,074 | -39,170 |
| total shareholders funds | -192,602 | 441,111 | -1,332,280 | -803,074 | -39,170 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 103,462 | 218,469 | 193,652 | 156,863 | 71 |
| Amortisation | |||||
| Tax | 202,366 | 255,748 | |||
| Stock | |||||
| Debtors | 281,334 | 680,704 | 464,673 | 62,688 | 307,128 |
| Creditors | -55,695 | -13,152 | 14,852 | 35,339 | 23,440 |
| Accruals and Deferred Income | 92,308 | 11,125 | 113,137 | 54,142 | 16,592 |
| Deferred Taxes & Provisions | |||||
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | |||||
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | |||||
| Group/Directors Accounts | 850,332 | -1,225,581 | 714,582 | 1,335,994 | 324,155 |
| Other Short Term Loans | |||||
| Long term loans | |||||
| Hire Purchase and Lease Commitments | |||||
| other long term liabilities | |||||
| share issue | |||||
| interest | |||||
| cash flow from financing | -1,225,581 | 714,582 | |||
| cash and cash equivalents | |||||
| cash | 1,178 | -446 | -53,478 | 184,839 | 5,634 |
| overdraft | |||||
| change in cash | 1,178 | -446 | -53,478 | 184,839 | 5,634 |
inspire neurocare limited Credit Report and Business Information
Inspire Neurocare Limited Competitor Analysis
Perform a competitor analysis for inspire neurocare limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other mid companies, companies in EC3R area or any other competitors across 12 key performance metrics.
inspire neurocare limited Ownership
INSPIRE NEUROCARE LIMITED group structure
Inspire Neurocare Limited has no subsidiary companies.
Ultimate parent company
OCTOPUS HEALTHCARE FUND
#0066766
2 parents
INSPIRE NEUROCARE LIMITED
11926195
inspire neurocare limited directors
Inspire Neurocare Limited currently has 3 directors. The longest serving directors include Mr Daniel Kay (Apr 2019) and Mr Timothy Street (Apr 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Daniel Kay | England | 55 years | Apr 2019 | - | Director |
| Mr Timothy Street | England | 50 years | Apr 2019 | - | Director |
| Mr Mark Gross | England | 46 years | Nov 2024 | - | Director |
P&L
December 2023turnover
7.5m
+117%
operating profit
-640.9k
0%
gross margin
38.2%
+23.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-192.6k
-1.44%
total assets
2.1m
+0.14%
cash
137.7k
+0.01%
net assets
Total assets minus all liabilities
Similar Companies
inspire neurocare limited company details
company number
11926195
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
April 2019
age
6
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
HAZLEWOODS LLP
auditor
-
address
10 lower thames street, london, EC3R 6AF
Bank
-
Legal Advisor
-
inspire neurocare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to inspire neurocare limited. Currently there are 1 open charges and 1 have been satisfied in the past.
inspire neurocare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INSPIRE NEUROCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
inspire neurocare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
